SEOUL -- Topcon Corporation (HQ: Itabashi-ku, Tokyo; President: Takashi Eto) (henceforth Topcon Healthcare) has established Topcon Korea Medical Co., Ltd. (HQ: Seoul, South Korea, President: Artur Chu) (henceforth TKM) to strengthen and expand its eyecare business in South Korea.

The company was registered in March 2023, and full-scale sales and marketing operations began in the second half of 2023 after the company's infrastructure and team staff were established. In South Korea, as in other developed countries, the government is responding to the increase in eye disease associated with an aging population. South Korea is focusing on a strategy of early detection and treatment applied broadly across the eye care sector to meet the high and increasing demand for examination through treatment.

The optical stores market in Korea is a different domain. It is highly competitive. The global economy and COVID-19 have affected it seriously; however, in accordance with increased demand for good quality lenses for myopia and presbyopia, business opportunities are recovering.

TKM is ready to contribute to each market to optimize the workflow and profitable management.

TKM is a strong partner for all eye care professionals, providing innovative products and services required by customers in the fields of optical business and ophthalmology, as well as new areas, including health check-ups and other medical specialties, to improve the quality and efficiency of healthcare.　

Message from the President, Artur Chu

“Introducing Topcon Korea Medical Co., Ltd., empowering excellence in the Korean market. With a firm foundation built on understanding the needs of our customers in Korea, TKM is poised to revolutionize the industry landscape. Our dedication to quality, innovation, and a deep understanding of business ensures that we not only meet but exceed the expectations of our Korean partners. Join us on this exciting journey as we redefine possibilities in Korea.”